Are patients with heart failure and chronic kidney disease less likely to be prescribed and adhere to guideline-recommended medical therapies?
There are significant gaps in the prescription, dispensation, and adherence to guideline-directed medical therapies among patients with concurrent heart failure and chronic kidney disease.
Patients with HF and CKD are less likely to be prescribed and to fill prescriptions for evidence-based therapies, showing lower adherence and persistence, even at eGFR categories where these therapies are recommended and have shown efficacy in clinical trials.
Janse et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: